EULAR 2011 - Vidofludimus Superior To Cyclophosphamide And MMF In An Experimental Sys
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data on vidofludimus - its lead small-molecule drug candidate against autoimmune diseases - in systemic lupus erythematosus (SLE) at EULAR 2011, Europe's largest scientific conference on rheumatic diseases, i...
The Following User Says Thank You to RSS Bot For This Useful Post:
lots of big words made this report hard to read.
but the drug appears to be good.
it again will not cure lupus, but will be used to contol it.